All Topics

New policies and technology now enable the government to detect healthcare fraud at scale and speed, raising the stakes for companies and investors. Advanced artificial intelligence tools and cross-agency data sharing have transformed enforcement capabilities, creating new exposure risks for healthcare and life sciences companies that depend on government payments.

A federal judge in Florida has ruled that cell phone users cannot sue under the TCPA's do-not-call provisions, determining that the FCC exceeded its authority when it extended protections to wireless subscribers in 2003. The decision challenges decades of regulatory interpretation and could fundamentally reshape telecommunications privacy litigation if adopted by other courts.

A federal appeals court has vacated EPA's 2024 methylene chloride risk management rule, finding the agency exceeded its statutory authority and failed to meet evidentiary standards under TSCA. The Fifth Circuit's comprehensive decision addresses fundamental questions about how EPA must conduct chemical risk evaluations, determine unreasonable risk, and impose regulatory controls—potentially reshaping the entire TSCA program for both existing and new chemicals.